A double blind study of 1-dopa treatment in Parkinson's disease.
D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D005116:Extrapyramidal Tracts / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009068:Movement; D010243:Paralysis; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D011674:Pulse; D011930:Reaction Time; D014159:Transducers; D014202:Tremor / Q000188:drug therapy
D004295:Dihydroxyphenylalanine